PCI Pharma Services: Overcoming Solubility Challenges in Targeted Oral Solid Dose Therapies

Practical formulation and bioavailability enhancement strategies to overcome poorly soluble molecules in oncology and targeted small-molecule therapeutics.

Access the executive summary for key takeaways →

LEAVE A REPLY

Please enter your comment!
Please enter your name here